| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | OTC PINK Exchange | 41151J307 CUSIP |
| US Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
The described company is an investment fund that focuses primarily on equity securities, with a spotlight on common stocks that show a promising potential for growth driven by disruptive innovation. The company places a high value on pioneering developments in products, services, technology, and other areas that possess the potential to overhaul current businesses and their existing models. While its primary interest lies in U.S. companies, the fund also allows for significant diversification of its portfolio by investing up to 25% of its assets in foreign securities, which may include companies located in emerging market countries. This strategy highlights the fund’s approach to capturing growth opportunities globally while remaining attentive to innovative disruptions across various sectors.
Focusing mainly on acquiring equity securities, principally in the form of common stocks, this fund targets companies with high growth potential through disruptive innovations. The investment in equity securities is the core offering, aiming to capitalize on the advancements and significant market shifts that innovative companies can bring about.
The fund identifies and invests in companies leading or on the cusp of disruptive innovation. Defining "disruptive innovation" as advancements in products, services, or technologies that are poised to transform existing industries and markets, the fund seeks to offer its investors exposure to pioneering companies that have the potential to redefine their sectors.
Expanding beyond the U.S. market, the fund is permitted to invest up to a quarter of its portfolio in foreign securities. This includes potential investments in emerging markets, thereby diversifying its investment scope and tapping into the global market's potential for innovation and growth.